Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$45.64

-0.41 (-0.89%)

07:26
10/04/16
10/04
07:26
10/04/16
07:26

SAGE Therapeutics reinstated with an Outperform at Leerink

Leerink analyst Paul Matteis resumed coverage of SAGE Therapeutics with an Outperform rating and $68 price target.

  • 07

    Oct

  • 06

    Nov

SAGE Sage Therapeutics
$45.64

-0.41 (-0.89%)

08/10/16
RHCO
08/10/16
NO CHANGE
RHCO
SAGE Therapeutics shares should be bought following decline, says SunTrust
After SAGE announced that the results of a Phase III trial of its SRSE drug would be delayed until 1H17 from 2H16 due to slower than expected enrollment, SunTrust analyst Edward Nash says the delay does not affect his timetable for the drug's commercial launch. The analyst does not expect changes to the protocol amendment to meaningfully affect patient characteristics or the results. He reiterates a $95 price target and Buy rating on the shares.
09/06/16
ADAM
09/06/16
NO CHANGE
Target $110
ADAM
Buy
SAGE Therapeutics breakthrough designation rare for FDA, says Canaccord
Canaccord analyst John Newman said SAGE Therapeutics' breakthrough designation for SAGE-547 is rare for the FDA to give in central nervous system disorders, suggesting the agency was impressed with the clinical data. Newman expects the breakthrough status to shorten the regulatory timing and allow for more flexibility in study design. The analyst rates SAGE a Buy with a $110 price target.
09/07/16
ROTH
09/07/16
NO CHANGE
Target $149
ROTH
Buy
Ligand has 'major catalyst' ahead, says Roth Capital
Roth Capital analyst Joseph Pantginis says Ligand (LGND) is expecting a "major catalyst" this month namely the Phase IIb sparsentan data in focal segmental glomerulosclerosis patients being developed by partner Retrophin (RTRX). In a separate note to investors, Pantginis also said that the Breakthrough Therapy Designation of SAGE Therapeutics' (SAGE) '547 for postpartum depression may expedite its development and approval for use in the clinic, noting that the company has an agreement of 3% royalty payment to Ligand for potential sales of the drug. The analyst recommends steady accumulation of Ligand's stock as he anticipates that current revenue streams from partnered products and the broad "in development" portfolio are poised to drive significant growth in the near and longer term. He reiterates a Buy rating and $149 price target on Ligand's shares.
09/13/16
RAJA
09/13/16
INITIATION
Target $75
RAJA
Outperform
SAGE Therapeutics initiated with an Outperform at Raymond James
Raymond James analyst Christopher Raymond initiated SAGE Therapeutics with an Outperform and a $75 price target. Raymond likes the setup on SAGE shares as key validation of its unique central nervous system drug development approach nears through pivotal SAGE-547 data, expected 1H 2017. Combining this with a pipeline holding numerous unmodeled call options and a platform capable of generating novel agents in a space lacking innovation, he believes shares will move higher.

TODAY'S FREE FLY STORIES

HAWK

Blackhawk

$36.50

-0.5 (-1.35%)

12:23
01/16/18
01/16
12:23
01/16/18
12:23
Downgrade
Blackhawk rating change  »

Blackhawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOO

Steven Madden

$48.20

-0.1 (-0.21%)

12:21
01/16/18
01/16
12:21
01/16/18
12:21
Hot Stocks
Steve Madden reports 7.52% stake in Steven Madden »

Steven Madden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$45.45

0.8494 (1.90%)

12:20
01/16/18
01/16
12:20
01/16/18
12:20
Options
Notable call buying in Teradyne ahead of earnings »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

MRK

Merck

$62.74

4.081 (6.96%)

, GE

General Electric

$18.09

-0.67 (-3.57%)

12:18
01/16/18
01/16
12:18
01/16/18
12:18
General news
On The Fly: Top stock stories at midday »

Stocks opened sharply…

MRK

Merck

$62.74

4.081 (6.96%)

GE

General Electric

$18.09

-0.67 (-3.57%)

UNH

UnitedHealth

$234.15

5.51 (2.41%)

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

AVGO

Broadcom

$264.29

0.79 (0.30%)

NXPI

NXP Semiconductors

$119.58

0.33 (0.28%)

GM

General Motors

$45.03

0.955 (2.17%)

UA

Under Armour; also tag UAA

$13.12

-1.025 (-7.25%)

UAA

Under Armour; also tag UA

$14.21

-0.915 (-6.05%)

SCOR

comScore

$29.10

0.305 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 06

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

$NSD

NASDAQ Market Internals

12:17
01/16/18
01/16
12:17
01/16/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/16/18
01/16
12:16
01/16/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOV

National Oilwell

$38.90

-0.24 (-0.61%)

12:15
01/16/18
01/16
12:15
01/16/18
12:15
Options
National Oilwell put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

DPW

DPW Holdings

$2.41

-0.325 (-11.90%)

12:12
01/16/18
01/16
12:12
01/16/18
12:12
Hot Stocks
DPW Holdings falls almost 12% after announcing conversion of notes »

Sandstone Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBOW

SilverBow Resources

$31.88

-0.9386 (-2.86%)

12:10
01/16/18
01/16
12:10
01/16/18
12:10
Conference/Events
SilverBow Resources management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$56.92

1.565 (2.83%)

12:07
01/16/18
01/16
12:07
01/16/18
12:07
Hot Stocks
LEGO Group, Tencent form partnership in China »

The LEGO Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$101.32

0.35 (0.35%)

12:06
01/16/18
01/16
12:06
01/16/18
12:06
Hot Stocks
American Express reports December net write-off rate 2.0% vs. 1.9% last month »

Reports December 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

BX

Blackstone

$35.81

0.42 (1.19%)

12:05
01/16/18
01/16
12:05
01/16/18
12:05
Options
Blackstone call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ICBK

County Bancorp

$30.16

0.38 (1.28%)

, MTW

Manitowoc

$40.09

0.73 (1.85%)

12:04
01/16/18
01/16
12:04
01/16/18
12:04
Hot Stocks
ICB to purchase Manitowoc Company headquarters »

Investors Community Bank,…

ICBK

County Bancorp

$30.16

0.38 (1.28%)

MTW

Manitowoc

$40.09

0.73 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$31.78

0.405 (1.29%)

12:02
01/16/18
01/16
12:02
01/16/18
12:02
Hot Stocks
Roche launches CE-marked VENTANA MMR IHC Panel »

Roche announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 23

    Feb

NSRGY

Nestle

$85.10

0.58 (0.69%)

12:02
01/16/18
01/16
12:02
01/16/18
12:02
Hot Stocks
Nestle agrees to sell U.S. confectionery business to Ferrero »

Nestle announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$54.16

-0.38 (-0.70%)

12:00
01/16/18
01/16
12:00
01/16/18
12:00
Periodicals
Hess to cut hundreds of jobs as it battles activist shareholder, Reuters says »

Hess plans to lay off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CECE

CECO Environmental

$5.22

-0.07 (-1.32%)

12:00
01/16/18
01/16
12:00
01/16/18
12:00
Hot Stocks
CECO Environmental reports award of 'large contract' to energy business »

CECO Environmental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

INFO

IHS Markit

$47.85

0.39 (0.82%)

11:55
01/16/18
01/16
11:55
01/16/18
11:55
Conference/Events
IHS Markit management to meet with RBC Capital »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

GSK

GlaxoSmithKline

$37.74

0.24 (0.64%)

11:54
01/16/18
01/16
11:54
01/16/18
11:54
Upgrade
GlaxoSmithKline rating change  »

GlaxoSmithKline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

GSK

GlaxoSmithKline

$37.76

0.2646 (0.71%)

11:51
01/16/18
01/16
11:51
01/16/18
11:51
Upgrade
GlaxoSmithKline rating change  »

GlaxoSmithKline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

SPY

SPDR S&P 500 ETF Trust

$278.99

1.07 (0.39%)

, SPX

S&P 500

11:50
01/16/18
01/16
11:50
01/16/18
11:50
Periodicals
Steve Bannon subpoenaed before grand jury by Mueller, NY Time says »

Special counsel Robert…

SPY

SPDR S&P 500 ETF Trust

$278.99

1.07 (0.39%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$11.67

0.1978 (1.72%)

11:50
01/16/18
01/16
11:50
01/16/18
11:50
Options
Large spreads in Petrobras as shares reach 52-week highs »

Large spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$62.38

3.72 (6.34%)

11:45
01/16/18
01/16
11:45
01/16/18
11:45
Options
Merck call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 25

    Mar

  • 03

    Apr

  • 23

    Oct

11:45
01/16/18
01/16
11:45
01/16/18
11:45
General news
Treasury's $90 B bill auction were mixed, with the 3-month outperforming »

Treasury's $90 B…

TTMI

TTM Technologies

$17.39

0.59 (3.51%)

11:45
01/16/18
01/16
11:45
01/16/18
11:45
Conference/Events
TTM Technologies management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.